[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"law-eurlex-reg_2012_823-de":3},{"abbreviation":4,"title":5,"source_type":6,"total":7,"offset":8,"entries":9},"reg_2012_823","zur Festlegung von von der Durchführungsverordnung (EU) Nr. 540\u002F2011 abweichenden Fristen für die Genehmigung der Wirkstoffe 2,4-DB, Benzoesäure, beta-Cyfluthrin, Carfentrazon-ethyl, Coniothyrium minitans Stamm CON\u002FM\u002F91-08 (DSM 9660), Cyazofamid, Cyfluthrin, Deltamethrin, Dimethenamid-P, Ethofumesat, Ethoxysulfuron, Fenamidon, Flazasulfuron, Flufenacet, Flurtamon, Foramsulfuron, Fosthiazat, Imazamox, Iodosulfuron, Iprodion, Isoxaflutol, Linuron, Maleinsäurehydrazid, Mecoprop, Mecoprop-P, Mesosulfuron, Mesotrion, Oxadiargyl, Oxasulfuron, Pendimethalin, Picoxystrobin, Propiconazol, Propineb, Propoxycarbazon, Propyzamid, Pyraclostrobin, Silthiofam, Trifloxystrobin, Warfarin und Zoxamid","eurlex",7,0,[10,15,18,21,24,27,31],{"norm_key":11,"title":12,"chapter":13,"slug":14},"ErwGr. 1",null,"Erwägungsgründe","erwgr-1",{"norm_key":16,"title":12,"chapter":13,"slug":17},"ErwGr. 2","erwgr-2",{"norm_key":19,"title":12,"chapter":13,"slug":20},"ErwGr. 3","erwgr-3",{"norm_key":22,"title":12,"chapter":13,"slug":23},"ErwGr. 4","erwgr-4",{"norm_key":25,"title":12,"chapter":13,"slug":26},"ErwGr. 5","erwgr-5",{"norm_key":28,"title":29,"chapter":12,"slug":30},"Art. 1","Befristungen","art-1",{"norm_key":32,"title":33,"chapter":12,"slug":34},"Art. 2","Inkrafttreten","art-2"]